The 4th ANZ Biologics Festival 2026 unites biopharma leaders to advance Australia & New Zealand's biologics industry through innovation partnerships and manufacturing expansion.
Key Themes & Topics
R&D Innovation & Antibody Engineering
Explore new discoveries in biologics R&D, like monoclonal and bispecific antibodies, fusion proteins and next-gen treatments driving biopharma innovation.
Manufacturing Excellence & Scalability
Learn about new ways to improve manufacturing, from upstream to downstream, using single-use systems, digital tools and scalable processes to increase efficiency and quality.
Clinical Trials & Regulatory Insights
Get insights on running early-phase clinical trials in ANZ, using flexible trial designs, speeding up approvals and aligning with global standards.
Supply Chain Optimisation
Explore cold chain logistics, smart packaging, temperature tracking and ways to keep the supply chain strong across ANZ.
Analytical & Quality Control Technologies
Learn about the latest tools for biologics production, including GMP testing, real-time monitoring, automated quality checks and product comparison methods.
AI, Automation & Digital Transformation
See how AI, digital twins, and automation are changing biologics manufacturing by improving maintenance, control and overall processes.
What to Expect at the 4th ANZ Biologics Festival 2026
Attendees
Join over 500 professionals at the 4th ANZ Biologics Festival! This is your chance to connect with key industry players, expand your network, and engage in high-level discussions that will shape the future of biologics.
Companies
Meet 150 leading companies driving innovation in the biologics sector. Whether you're looking for new partners or exploring the latest breakthroughs, this is the perfect platform to discover what’s next in the industry.
Speakers
Gain exclusive insights from 50 expert speakers who are shaping the future of biologics. Learn from the best in the field as they share cutting-edge knowledge, practical solutions, and emerging trends you can’t afford to miss.
Testimonials
“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”
West Pharmaceutical Services Korea
“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”
West Pharmaceutical Services Korea
“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”
West Pharmaceutical Services Korea
“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”
West Pharmaceutical Services Korea
CONCEPT
Excellence in Biologics, CGT & RNA Therapeutics for ANZ’s Biopharma Future
Australia & New Zealand are emerging as global leaders in biologics, backed by world-class research, facilities, and regulation. But unlocking the full potential of the sector will require stronger commercial translation, local manufacturing, and strategic partnerships. The 4th ANZ Biologics Festival 2026 brings together innovators in biologics, biosimilars, vaccines, CGT, and RNA therapeutics — from discovery to commercialization. It’s the go-to platform to connect with ANZ’s growing biopharma ecosystem and explore investment, innovation, and manufacturing opportunities. With dedicated tracks on Biologics Manufacturing, Cell & Gene Therapy, and RNA Therapeutics, this is where ANZ’s biologics future takes shape.
WHO
Bringing together Big Pharma, ANZ Biopharma, APAC & global players, regulators, CROs, CMOs, research institutes, NGOs, investors, and top solution providers.
WHAT
A platform to unlock partnerships, scale innovation, and advance manufacturing in Australia & New Zealand.
WHY
With 1,300+ life sciences companies, 70+ research institutes, 150+ listed biopharmas, and strong medtech innovation, ANZ is a rising biotech powerhouse.
CONTACT
Lara Santiago, Senior Portfolio Specialist
p: +63 9176 210686
Caterin Sanggita, Conference Producer
e: caterin.sanggita@imapac.com
p: +65 6983 6137
Charmaine Poh, Business Development Manager
m: +65 6983 6133
Ana Laxamana, Regional Business Development Lead
m: +65 6983 6132
Share With Your Network
